Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

  • Home
  • /
  • Bodal Chemicals
Join Channel
Consolidated Standalone

Bodal Chemicals

₹72.6 0.7 | 1%

Market Cap ₹913 Cr.

Stock P/E 126.0

P/B 0.9

Current Price ₹72.6

Book Value ₹ 85.3

Face Value 2

52W High ₹101

Dividend Yield 0.14%

52W Low ₹ 64

Edit Ratio

Bodal Chemicals Research see more...

Overview Inc. Year: 1986Industry: Dyes & Pigments

Bodal Chemicals Ltd is an totally India-based holding business enterprise. The Company, via its subsidiaries, is engaged in manufacturing of dyestuffs, dyes intermediates and basic chemicals. Its geographic segments include domestic operations and external operations. The Company produces a variety of chemical compounds, that are used as raw materials for dye intermediates and dyestuff. Its products encompass Vinyl Sulphone Ester, H Acid, F C Acid, DASA, Gama Acid, 6 Nitro, Acid Black 210, Reactive Black BL/GR, Reactive Black B, Reactive Black 5, Acid Black 194, Sulphuric Acid, Oleum, Sulphur Trioxide and Chlorosulphonic Acid. It manufactures over 20 sorts of dye intermediates and over 150 versions in dyestuff, which might be used as raw materials in fabric, leather, paper and other dye ingesting industries. The Company's production plants are located in Vatva, Ahmedabad; Bharuch, Gujarat, and Vadodara, Gujarat. It exports its products to Thailand, Taiwan, China, Korea, Japan and Europe.

Read More..

Bodal Chemicals Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Bodal Chemicals Quarterly Results

#(Fig in Cr.) Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 470 562 600 463 401 321 390 332 330 339
Other Income 2 7 2 4 2 2 4 9 6 5
Total Income 471 568 603 467 403 323 393 341 336 343
Total Expenditure 421 493 551 413 369 296 363 310 307 315
Operating Profit 50 75 52 54 34 27 31 31 29 29
Interest 6 9 6 12 7 10 12 13 13 12
Depreciation 12 12 12 12 12 14 15 15 14 15
Exceptional Income / Expenses 0 -19 0 0 0 0 0 0 0 0
Profit Before Tax 32 35 34 29 14 3 5 3 2 2
Provision for Tax 10 15 9 7 4 0 2 1 0 1
Profit After Tax 22 20 25 23 10 2 3 2 1 1
Adjustments 1 4 0 0 0 0 0 0 0 0
Profit After Adjustments 23 24 25 23 10 2 3 2 1 1
Adjusted Earnings Per Share 1.9 2 2 1.8 0.8 0.2 0.2 0.2 0.1 0.1

Bodal Chemicals Profit & Loss

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 527 960 1045 910 1234 1142 1424 1375 1226 2055 1574 1391
Other Income 4 4 5 12 11 9 13 10 16 17 12 24
Total Income 531 963 1050 922 1245 1152 1437 1385 1242 2072 1586 1413
Total Expenditure 508 771 861 760 1008 948 1187 1237 1140 1835 1441 1295
Operating Profit 24 192 189 162 237 204 249 148 103 237 145 120
Interest 40 47 27 12 9 5 9 19 17 29 41 50
Depreciation 16 25 22 26 29 12 21 28 30 47 53 59
Exceptional Income / Expenses 0 -74 0 7 5 0 0 0 0 -19 0 0
Profit Before Tax -33 47 139 131 204 186 219 101 55 142 51 12
Provision for Tax -10 16 47 45 71 62 77 15 16 43 13 4
Profit After Tax -23 30 92 86 133 125 142 86 40 99 38 7
Adjustments 0 0 0 0 -0 -2 1 1 2 6 0 0
Profit After Adjustments -23 30 92 86 133 123 143 87 42 104 38 7
Adjusted Earnings Per Share -2.1 2.8 8.4 7.9 12.2 10 11.7 7.1 3.4 8.5 3 0.6

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -23% 5% 7% 12%
Operating Profit CAGR -39% -1% -7% 20%
PAT CAGR -62% -24% -21% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 7% -12% -8% 11%
ROE Average 4% 6% 9% 23%
ROCE Average 5% 7% 11% 21%

Bodal Chemicals Balance Sheet

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 50 90 181 235 363 697 829 931 981 1052 1078
Minority's Interest 0 0 0 0 2 1 1 7 5 0 0
Borrowings 246 216 86 1 8 1 13 0 106 214 362
Other Non-Current Liabilities -2 -0 12 15 18 24 36 23 46 43 60
Total Current Liabilities 177 287 254 259 316 348 411 495 610 794 621
Total Liabilities 471 593 534 510 707 1072 1290 1455 1749 2113 2120
Fixed Assets 265 168 190 192 222 437 609 656 804 817 967
Other Non-Current Assets 16 27 22 11 80 98 66 41 74 166 302
Total Current Assets 190 397 323 307 405 537 616 758 871 1122 851
Total Assets 471 593 534 510 707 1072 1290 1455 1749 2113 2120

Bodal Chemicals Cash Flow

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 2 0 1 1 0 14 1 8 14 12 9
Cash Flow from Operating Activities 14 49 198 131 104 7 186 10 -13 -14 285
Cash Flow from Investing Activities -2 -17 -35 -23 -68 -256 -128 -81 -168 -170 -310
Cash Flow from Financing Activities -13 -32 -162 -109 -23 236 -51 76 178 181 33
Net Cash Inflow / Outflow -1 1 0 -1 13 -13 7 5 -3 -3 8
Closing Cash & Cash Equivalent 0 1 1 0 14 1 8 14 12 9 17

Bodal Chemicals Ratios

# Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) -2.12 2.76 8.41 7.88 12.18 10.03 11.72 7.13 3.43 8.51 3.03
CEPS(Rs) -0.61 5.08 10.45 10.24 14.83 11.19 13.38 9.35 5.74 11.86 7.25
DPS(Rs) 0 0 0 0.6 0.8 0.8 0.8 0.8 0.8 0.8 0.1
Book NAV/Share(Rs) 3.2 5.95 14.34 21.5 33.24 57.01 67.73 72.52 80.05 85.83 85.68
Core EBITDA Margin(%) 3.45 18.2 16.32 15.15 16.88 16.67 16.59 10.01 7.06 10.69 8.47
EBIT Margin(%) 1.25 9.02 14.76 14.43 15.87 16.45 16.03 8.7 5.87 8.35 5.84
Pre Tax Margin(%) -5.74 4.49 12.34 13.2 15.22 15.99 15.4 7.32 4.52 6.91 3.23
PAT Margin (%) -4.04 2.91 8.13 8.7 9.93 10.68 9.99 6.26 3.24 4.8 2.42
Cash Profit Margin (%) -1.16 5.34 10.11 11.3 12.08 11.72 11.48 8.32 5.73 7.07 5.79
ROA(%) -4.43 5.67 16.29 16.47 21.85 14.01 12.04 6.27 2.48 5.11 1.8
ROE(%) -49.74 60.46 82.92 43.97 44.51 23.52 18.66 10.04 4.26 9.72 3.58
ROCE(%) 1.79 21.75 39.09 37.18 47.7 27.56 24.3 10.94 5.49 10.85 5.15
Receivable days 77.18 55.44 68.5 67.15 54.1 90.31 86.73 104.06 137.17 93.89 117.07
Inventory Days 45.02 32.35 32.36 30.96 30.07 38.21 41.15 56.64 78.31 66.76 85.46
Payable days 91.39 53.3 62.32 69.46 60.36 80.41 77.03 89.22 99.21 75.7 89.71
PER(x) 0 6.84 4.01 9.29 13.15 12.12 10.82 5.94 26.24 11.85 19.07
Price/Book(x) 1.85 3.18 2.35 3.41 4.82 2.13 1.87 0.58 1.12 1.17 0.67
Dividend Yield(%) 0 0 0 0.82 0.5 0.66 0.63 1.89 0.89 0.79 0.17
EV/Net Sales(x) 0.8 0.62 0.57 1.03 1.53 1.45 1.2 0.55 1.25 0.92 0.93
EV/Core EBITDA(x) 17.92 3.11 3.17 5.8 7.96 8.15 6.86 5.1 15.01 8 10.12
Net Sales Growth(%) -14.05 81.91 8.94 -12.95 35.66 -7.47 24.63 -3.42 -10.79 67.58 -23.4
EBIT Growth(%) 216.38 1202.96 78.08 -14.28 48.9 -9.76 19.01 -47.57 -39.8 138.12 -46.44
PAT Growth(%) 22.4 230.29 204.29 -6.31 54.59 -6.27 14.12 -39.49 -53.78 148.1 -61.45
EPS Growth(%) 22.27 230.28 204.29 -6.31 54.57 -17.66 16.84 -39.2 -51.84 147.96 -64.42
Debt/Equity(x) 6.91 4.13 1.15 0.61 0.42 0.26 0.21 0.29 0.46 0.64 0.71
Current Ratio(x) 1.07 1.38 1.27 1.19 1.28 1.54 1.5 1.53 1.43 1.41 1.37
Quick Ratio(x) 0.72 0.96 0.96 0.84 0.87 1.22 0.99 1.09 0.92 0.85 0.9
Interest Cover(x) 0.18 1.99 6.1 11.7 24.44 36.13 25.15 6.29 4.33 5.82 2.24
Total Debt/Mcap(x) 5.41 1.8 0.57 0.18 0.09 0.12 0.11 0.5 0.41 0.55 1.05

Bodal Chemicals Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 58.94 58.94 58.94 58.86 57.47 57.47 57.39 57.39 57.39 57.39
FII 2.99 2.97 3.06 3.09 2.42 2.43 2.37 0.45 0.3 0.77
DII 0.15 0.17 0.17 0.17 0.17 0.14 0.01 0.03 0.01 0.01
Public 37.92 37.91 37.82 37.87 39.94 39.96 40.22 42.12 42.29 41.82
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Stock is trading at 0.9 times its book value

Cons

  • Company has a low return on equity of 6% over the last 3 years.
  • Debtor days have increased from 75.7 to 89.71days.
  • The company has delivered a poor profit growth of -21% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Bodal Chemicals News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!